Follow
Matthew W. Johnson
Matthew W. Johnson
Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University
Verified email at jhu.edu - Homepage
Title
Cited by
Cited by
Year
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
RR Griffiths, MW Johnson, MA Carducci, A Umbricht, WA Richards, ...
Journal of Psychopharmacology 30 (12), 1181-1197, 2016
18602016
Within‐subject comparison of real and hypothetical money rewards in delay discounting
MW Johnson, WK Bickel
Journal of the experimental analysis of behavior 77 (2), 129-146, 2002
12282002
Human hallucinogen research: guidelines for safety
MW Johnson, WA Richards, RR Griffiths
Journal of Psychopharmacology 22 (6), 603-620, 2008
11202008
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
RR Griffiths, WA Richards, MW Johnson, UD McCann, R Jesse
Journal of psychopharmacology 22 (6), 621-632, 2008
10542008
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu, MP Cosimano, RR Griffiths
Journal of Psychopharmacology 28 (11), 983-992, 2014
9512014
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
KA MacLean, MW Johnson, RR Griffiths
Journal of Psychopharmacology 25 (11), 1453-1461, 2011
9302011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
RR Griffiths, MW Johnson, WA Richards, BD Richards, U McCann, ...
Psychopharmacology 218, 649-665, 2011
9212011
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ...
JAMA psychiatry 78 (5), 481-489, 2021
8912021
Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude.
F Baker, MW Johnson, WK Bickel
Journal of abnormal psychology 112 (3), 382, 2003
7542003
The behavioral economics of substance use disorders: reinforcement pathologies and their repair
WK Bickel, MW Johnson, MN Koffarnus, J MacKillop, JG Murphy
Annual review of clinical psychology 10, 641-677, 2014
6362014
Long-term follow-up of psilocybin-facilitated smoking cessation
MW Johnson, A Garcia-Romeu, RR Griffiths
The American journal of drug and alcohol abuse 43 (1), 55-60, 2017
6072017
An algorithm for identifying nonsystematic delay-discounting data.
MW Johnson, WK Bickel
Experimental and clinical psychopharmacology 16 (3), 264, 2008
5172008
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction
A Garcia-Romeu, R R Griffiths, M W Johnson
Current drug abuse reviews 7 (3), 157-164, 2014
4972014
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and …
RR Griffiths, MW Johnson, WA Richards, BD Richards, R Jesse, ...
Journal of Psychopharmacology 32 (1), 49-69, 2018
4732018
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
FS Barrett, MW Johnson, RR Griffiths
Journal of Psychopharmacology 29 (11), 1182-1190, 2015
4542015
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
TM Carbonaro, MP Bradstreet, FS Barrett, KA MacLean, R Jesse, ...
Journal of Psychopharmacology 30 (12), 1268-1278, 2016
4492016
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
PS Hendricks, CB Thorne, CB Clark, DW Coombs, MW Johnson
Journal of Psychopharmacology 29 (3), 280-288, 2015
4182015
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
MW Johnson, PS Hendricks, FS Barrett, RR Griffiths
Pharmacology & therapeutics 197, 83-102, 2019
4142019
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin
KA MacLean, JMS Leoutsakos, MW Johnson, RR Griffiths
Journal for the scientific study of religion 51 (4), 721-737, 2012
3822012
Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls
SH Heil, MW Johnson, ST Higgins, WK Bickel
Addictive Behaviors 31 (7), 1290-1294, 2006
3482006
The system can't perform the operation now. Try again later.
Articles 1–20